Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8
Published September 20, 2017 · Recall initiated: August 18, 2017
Summary
FDA records drug Class II recall D-1137-2017, published September 20, 2017 and initiated August 18, 2017. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 44800 bottles; Lot: Lot #: Z701133, Exp 03/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets
What to do
Voluntary: Firm initiated · Letter
Get an email if PAROXETINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PAROXETINE
- Manufacturer
- Zydus Pharmaceuticals USA Inc
- Distributor
- Nationwide within United States
- UPC
- 0368382098108
- Lot
- Lot #: Z701133, Exp 03/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDCDecember 6, 2023
- FDAParoxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-countDecember 6, 2023
- FDAParoxetine Hydrochloride Tablets USP, RX only, 10 mg a) 30-count bottle, NDC#: 60505-0097-1; b) 100-countDecember 6, 2023
- FDAPAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDCDecember 6, 2023
- FDADoctor Manzanilla Cough & Cold (diphenhydramine hydrochloride and phenylephrine hydrochloride) Syrup, 12.5 mgSeptember 20, 2017
- FDAVitamin A&D Ointment (petroleum 93.5%), Skin Protectant, NET Wt. 0.18 OZ (5g), Manufactured for MedlineSeptember 20, 2017
Questions about this recall
Was Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8 recalled?
Yes. FDA published recall D-1137-2017 on September 20, 2017. Reported hazard: Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PAROXETINE. UPC: 0368382098108.